Results 111 to 120 of about 20,619 (221)
Growth Differentiation Factor 15 in Patients with Acromegaly: A Case–Control Study
Objective: It was previously shown that the levels of several biomarkers increase due to acromegaly disease-related inflammation, and some markers are parallel to the disease’s activity.
Serdar Kayıhan +11 more
core +1 more source
Respiratory Dysfunctions in Acromegaly. Acromegaly and Sleep Apnea
, 2017 Introduction: Acromegaly refers to an abnormal growth of some bones and tissues due to excessive action of insulin-like growth factor-1 (IGF-1). It occurs after the growth plate cartilage fuses in adulthood.
Velieva, Mukates +4 more
core +1 more source
Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients [PDF]
Objective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology ...
Meriç Coşkun +13 more
core +1 more source
[What is the value of determining immunoreactive GHRH in acromegaly?]
, 1999 Acromegaly is usually due to autonomous, excessive secretion of growth hormone from a pituitary adenoma. One would expect growth hormone-releasing factor (GHRH) in these patients to be suppressed.
Bürgi, U +3 more
core
, 2014 Acromegaly - a neuroendocrine pathology, caused by chronic overproduction of growth hormone. Chronic overproduction of somatotropin and insulin growth factor (IGF) is clinically expressed in gigantism or acromegaly.
E L Soyustova
core +1 more source
Communication practices and awareness of resources for acromegaly patients among endocrinologists
, 2016 Susan Polanco-Briceno,1 Daniel Glass,1 Cindy Plunkett2 1Deerfield Institute, New York, NY, USA; 2Department of Internal Medicine, Metabolism Endocrinology & Diabetes (MEND), University of Michigan, Ann Arbor, MI, USA Purpose: This study was ...
Glass D, Polanco-Briceno S, Plunkett C
core
, 2015 Cynthia Plunkett, Ariel L BarkanDivision of Endocrinology, University of Michigan Medical Center, Ann Arbor, MI, USAAbstract: Patients with acromegaly (a condition of chronic growth hormone hypersecretion by a pituitary adenoma) often require ...
Plunkett C, Barkan AL
core
Cell death in acromegalic cardiomyopathy
, 1999 Prolonged untreated acromegaly leads to a nonspecific myopathy characterized by ventricular dysfunction and failure. However, the mechanisms responsible for the alterations of cardiac pump function remain to be defined.
Crea, Filippo +11 more
core